Sverre Holm Selected Research

DNA Glycosylases (DNA Glycosylase)

10/2021	NEIL3-deficiency increases gut permeability and contributes to a pro-atherogenic metabolic phenotype.
1/2021	DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development.
1/2016	Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sverre Holm Research Topics

Disease

26	Atherosclerosis 10/2021 - 08/2010
16	Carotid Artery Diseases 12/2020 - 08/2010
13	Inflammation (Inflammations) 10/2021 - 01/2010
12	Atherosclerotic Plaque (Atheroma) 10/2021 - 01/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 01/2014
4	Ischemic Stroke 12/2018 - 01/2011
4	Carotid Stenosis (Carotid Artery Stenosis) 07/2017 - 03/2015
3	Hypoxia (Hypoxemia) 01/2016 - 10/2011
2	Thrombosis (Thrombus) 10/2021 - 07/2017
2	Acute Coronary Syndrome 10/2020 - 11/2015
2	ST Elevation Myocardial Infarction 01/2020 - 01/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 07/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 01/2013
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Virus Diseases (Viral Diseases) 10/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2020
1	Necrosis 10/2020
1	Stable Angina 10/2020
1	Fatty Liver 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Rheumatic Diseases (Rheumatism) 10/2019
1	Transient Ischemic Attack 12/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2018
1	Pathologic Constriction (Stenosis) 01/2017
1	Myocardial Infarction 01/2016
1	Infections 01/2016
1	Non-alcoholic Fatty Liver Disease 07/2015
1	Disease Progression 03/2015

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 01/2021 - 08/2010
7	CytokinesIBA 10/2021 - 01/2014
7	EnzymesIBA 12/2020 - 08/2010
6	Apolipoproteins E (ApoE)IBA 10/2021 - 01/2013
6	LipidsIBA 01/2021 - 01/2014
5	CholesterolIBA 10/2020 - 01/2010
5	InterleukinsIBA 10/2020 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2010
4	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2015
3	DNA Glycosylases (DNA Glycosylase)IBA 10/2021 - 01/2016
3	ChemokinesIBA 01/2021 - 09/2012
3	lipoprotein-associated coagulation inhibitor (TFPI)IBA 07/2017 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 10/2011
2	LigandsIBA 01/2021 - 04/2014
2	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2020
2	Deoxyribonuclease (Pyrimidine Dimer)IBA 01/2021 - 01/2020
2	Inosine FDA Link 01/2021 - 01/2020
2	InflammasomesIBA 10/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2017
2	asparaginylendopeptidase (legumain)IBA 01/2020 - 01/2017
2	Cysteine Proteases (Cysteine Protease)IBA 01/2020 - 01/2017
2	ImmunosorbentsIBA 01/2017 - 07/2015
2	Thrombin FDA Link 01/2016 - 05/2012
2	InterferonsIBA 01/2016 - 05/2012
2	Interleukin-17 (Interleukin 17)IBA 03/2015 - 01/2013
2	Chemokine CXCL13IBA 06/2014 - 09/2012
2	oxidized low density lipoproteinIBA 01/2014 - 10/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2012 - 08/2010
1	VaccinesIBA 10/2021
1	ChAdOx1 nCoV-19IBA 10/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2021
1	Immunoglobulin G (IgG)IBA 10/2021
1	ApolipoproteinsIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 12/2020
1	6-methyladenineIBA 12/2020
1	N-methyladenosineIBA 12/2020
1	MethyltransferasesIBA 12/2020
1	Factor VaIBA 10/2020
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 10/2020
1	Complement System Proteins (Complement)IBA 10/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Lipoprotein(a)IBA 10/2019
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 12/2018
1	Thymidine Monophosphate (TMP)IBA 10/2018
1	Interleukin-27 (Interleukin 27)IBA 01/2017
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2017
1	NAD (NADH)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	gamma-butyrobetaine (butyrobetaine)IBA 04/2016
1	trimethyllysineIBA 04/2016
1	trimethyloxamine (trimethylamine N-oxide)IBA 04/2016
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2016
1	Thromboplastin (Tissue Factor)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	LectinsIBA 01/2016
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2016
1	DNA Repair EnzymesIBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	CoagulantsIBA 01/2016
1	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2015
1	Interleukin-12 (IL 12)IBA 03/2015
1	Interleukin-23 (Interleukin 23)IBA 03/2015
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2014
1	Caseins (Casein)FDA Link 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 01/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2014
1	Interleukin-9 (Interleukin 9)IBA 01/2013

Therapy/Procedure

1	Percutaneous Coronary Intervention 01/2020
1	Carotid Endarterectomy 07/2017